Skip to content

CO2 Laser to treat patients diagnosed with Hyperactive Bladder

CO2 Laser treatment on Hyperactive Bladder - LASER Light amplification by stimulated emission of radiation.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-10np4cyz
Enrollment
Unknown
Registered
2023-08-29
Start date
2023-07-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unspecified urinary incontinence

Interventions

This is a randomized clinical study with two arms. After signing the informed consent form, the patients will be randomized into LASER (L) or SHAM (S) groups. The randomization was performed using a c

Sponsors

Univesidade Federal de São Paulo
Lead Sponsor
Univesidade Federal de São Paulo
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Women diagnosed clinically with Overactive Bladder Syndrome; Age between 18 and 80 years; Signature of the consent form; A 3-day voiding diary showing 8 or more voids in 24 hours and at least 1 episode of urinary urgency.

Exclusion criteria

Exclusion criteria: Untreated urinary infection; untreated genital infection; Bladder Pain Syndrome; Neurogenic bladder; Stroke, neurological or neurodegenerative diseases; Genital prolapse of any compartment above the hymenal ring; Urinary tract lithiasis or tumors; Physiotherapeutic or drug treatment for SBH within the past 2 months.

Design outcomes

Primary

MeasureTime frame
Decrease in the number of daily voids by 3.5 in the LASER group and 2 in the SHAM group.

Secondary

MeasureTime frame
No secundary outcomes are expected.

Countries

Brazil

Contacts

Public ContactLuiza Morais

Univesidade Federal de São Paulo

luizarmorais@gmail.com+55(11)55764848

Outcome results

None listed

Source: REBEC (via WHO ICTRP)